With further optimization and targeting towards suitable industrial applications, the identified OSN stages are being scaled up and validated at pilot scale by AstraZeneca, to promote sustainability and enable broader benefits across the industry.
Find out more in this accessible two-page industrial case study arising from the ETERNAL Horizon Europe Research and Innovation Action.
This site uses cookies that enable us to make improvements, provide relevant content, and for analytics purposes. For more details, see our Cookie Policy. By clicking Accept, you consent to our use of cookies.